Estrogen receptors β1 and β2 have opposing roles in regulating proliferation and bone metastasis genes in the prostate cancer cell line PC3.
about
Oestrogens and oestrogen receptors in prostate cancerClinical significance of estrogen receptor β in breast and prostate cancer from biological aspectsEffect of estrogen receptor β agonists on proliferation and gene expression of ovarian cancer cellsERβ1 inhibits metastasis of androgen receptor-positive triple-negative breast cancer by suppressing ZEB1.Gender effect in experimental models of human medulloblastoma: does the estrogen receptor β signaling play a role?The role of estrogen receptor β in prostate cancer.A screening cascade to identify ERβ ligands.Estrogen Receptor β2 Induces Hypoxia Signature of Gene Expression by Stabilizing HIF-1α in Prostate Cancer.Estrogen Receptor β Agonists Differentially Affect the Growth of Human Melanoma Cell Lines.ERβ localization influenced outcomes of EGFR-TKI treatment in NSCLC patients with EGFR mutations.Altered expression of estrogen receptor β2 is associated with different biological markers and clinicopathological factors in papillary thyroid cancerLigand Independent and Subtype-Selective Actions of Thyroid Hormone Receptors in Human Adipose Derived Stem Cells.Prostate Cancer Expression Profiles of Cytoplasmic ERβ1 and Nuclear ERβ2 are Associated with Poor Outcomes following Radical Prostatectomy.Multiple direct and indirect mechanisms drive estrogen-induced tumor growth in high grade serous ovarian cancers.Estrogen receptors α and β and aromatase as independent predictors for prostate cancer outcomeLapatinib induces p27(Kip1)-dependent G₁ arrest through both transcriptional and post-translational mechanismsComprehensive assessment of estrogen receptor beta antibodies in cancer cell line models and tissue reveals critical limitations in reagent specificitySupport of a bi-faceted role of estrogen receptor β (ERβ) in ERα-positive breast cancer cellsRecepteur d'origine nantais (RON), more than a kinase: Role in castrate-resistant prostate cancer.The role of TWIST1 in epithelial-mesenchymal transition and cancers.Cancer in Transgender People: Evidence and Methodological Considerations.Structural and functional characteristics of estrogen receptor beta (ERβ) splice variants: implications for the aging brain.Estrogen and estrogen receptor alpha promotes malignancy and osteoblastic tumorigenesis in prostate cancer.Estrogen induces androgen-repressed SOX4 expression to promote progression of prostate cancer cells.Characterizing biomarkers in osteosarcoma metastasis based on an ego-network.Variant 2 of KIAA0101, antagonizing its oncogenic variant 1, might be a potential therapeutic strategy in hepatocellular carcinoma.Sexual dimorphism in medulloblastoma features.Sex Differences and Bone Metastases of Breast, Lung, and Prostate Cancers: Do Bone Homing Cancers Favor Feminized Bone Marrow?Complete response to ethnylestradiol prolonged for almost two years in patients with castration-resistant prostate cancer.Estradiol-ERβ2 signaling axis confers growth and migration of CRPC cells through TMPRSS2-ETV5 gene fusion.Identification of the G protein-coupled estrogen receptor (GPER) in human prostate: expression site of the estrogen receptor in the benign and neoplastic gland.In vitro chronic administration of ERbeta selective ligands and prostate cancer cell growth: hypotheses on the selective role of 3beta-adiol in AR-positive RV1 cells.Estrogen receptor beta 2 is associated with poor prognosis in estrogen receptor alpha-negative breast carcinoma.Markers of epithelial-to-mesenchymal transition reflect tumor biology according to patient age and Gleason score in prostate cancer.Estrogen receptor β2 induces proliferation and invasiveness of triple negative breast cancer cells: association with regulation of PHD3 and HIF-1α.Estrogen and Androgen Blockade for Advanced Prostate Cancer in the Era of Precision Medicine.The ERβ4 variant induces transformation of the normal breast mammary epithelial cell line MCF-10A; the ERβ variants ERβ2 and ERβ5 increase aggressiveness of TNBC by regulation of hypoxic signaling.Differential Effects of Estrogen Receptor β Isoforms on Glioblastoma Progression.Tracking Tumor Colonization in Xenograft Mouse Models Using Accelerator Mass SpectrometryReplication-dependent histone isoforms: a new source of complexity in chromatin structure and function
P2860
Q26749122-E0188DCB-9D66-43AC-833E-B3619CD3E458Q28087001-FD58DDDA-2561-4552-81AC-ADBE59029F5FQ33651509-93D9BFCB-9416-4C4E-9E5B-B860B3567CB4Q33768248-A6CD2964-691F-4166-A910-CACE6BDD427AQ33856461-FBF5CBBC-067B-416F-B3A7-CAA9A276EADDQ34416254-6DE94517-E888-4A2D-A84C-4D61EF4ABA61Q34564793-AFBD0C5F-0E28-44E6-A243-06202E337A06Q35641661-E2895C3D-B53E-4E8E-9AD0-2739F4082232Q35725686-A66525DD-9D8D-4355-918C-4C90C8D4705FQ35764673-5CA2B0E0-B2FF-490D-85AA-D6FF711AA49CQ35919319-C2FAC2F7-6859-43E8-902B-55574E761936Q36161537-E98FBC1C-712D-4233-B8CE-56CAA3FC4051Q36913512-73E59B1D-7923-4892-8EF8-31FA20BF9671Q36946741-C14DBC61-E6AD-475B-BC0F-C141313F7F68Q37244198-6A008C29-6743-4D11-A8E1-56283AC8834EQ37396923-8B57E110-4AB5-46C7-A3E0-7DCB26A3D5D9Q37582438-1CA2B5CC-E916-4E84-A9F1-C75466EC9093Q37624907-BB6B0595-665C-466C-8572-9B36B7FC4D31Q38543678-4E79B693-C20A-4EF3-8245-7EE224628538Q38646345-5C026E3F-B6E2-4214-A3B2-E11BCC973D5DQ38685944-6DB3E14B-E8B6-4C0D-B3CA-851D7AC7468FQ38780608-54B0B213-F35D-417B-AE23-4F8863AE4F08Q38819069-0FF2171B-3C49-45F6-8E67-28A91DA0C5A7Q38870511-580C3791-5F97-4D0E-BB8A-888905BFA869Q38947081-74EB578B-EBA2-43FB-A872-17B24E83F0F0Q40250784-BDF8DA42-34A1-422B-8AEC-D007E4FAE75FQ40778313-CAA372B3-AE8E-4AEB-B481-1F1D5A0AA3D8Q41273764-96EB103A-21F1-4918-A64B-8A99A27E1C43Q41809823-83C584CA-A136-41DD-8CE8-EAB0FCE9F10DQ42052829-79C81747-64A3-4647-9EBB-C125E5D6CFF5Q42486845-6978EA67-D0F7-4918-A764-47657008B6DEQ42573768-9A08B0D0-4796-4B8B-8B33-99280AA32317Q44380247-C73E3805-270A-4C91-A1AF-7BAD539B8DC0Q47177430-992EE99D-DDE3-4C7C-B53A-9189ED3F2C93Q47444410-38739643-96BD-44D7-AFC4-DACF11B6A555Q47717137-32C22CF1-27BA-437D-845D-C6996273AA69Q52649598-6808728F-93DD-4930-B87D-B5520EEF007BQ55457293-CD4B6577-1E53-40E0-881E-B62222640FA4Q57292362-0ED4EF71-1CF3-4903-9D10-D2BBC7240194Q58700196-04875B96-6905-44B7-AA84-ED3A81526151
P2860
Estrogen receptors β1 and β2 have opposing roles in regulating proliferation and bone metastasis genes in the prostate cancer cell line PC3.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Estrogen receptors β1 and β2 h ...... prostate cancer cell line PC3.
@ast
Estrogen receptors β1 and β2 h ...... prostate cancer cell line PC3.
@en
type
label
Estrogen receptors β1 and β2 h ...... prostate cancer cell line PC3.
@ast
Estrogen receptors β1 and β2 h ...... prostate cancer cell line PC3.
@en
prefLabel
Estrogen receptors β1 and β2 h ...... prostate cancer cell line PC3.
@ast
Estrogen receptors β1 and β2 h ...... prostate cancer cell line PC3.
@en
P2860
P50
P356
P1476
Estrogen receptors β1 and β2 h ...... prostate cancer cell line PC3
@en
P2093
Anders Ström
Jan-Åke Gustafsson
P2860
P304
P356
10.1210/ME.2012.1227
P577
2012-10-01T00:00:00Z